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CLINICAL INVESTIGATION
Expression of leucocyte and lymphocyte adhesion molecules in
the human kidney
G. ALEX BISHOP and BRUCE M. HALL
Department of Medicine, Division of Nephrology, Stanford University Medical Center, Stanford, California, USA
Expression of leucocyte and lymphocyte adhesion molecules in the
human kidney. Leucocyte interaction with other cells is facilitated by
the adhesion molecules, leucocyte function-associated antigen-I (LFA-
1)-binding to intercellular adhesion molecule-! (ICAM-!) and for T cells
and natural killer (NK) cells the binding of LFA-2 (CD2) to LFA-3. As
these interactions are critical for the mediation of graft destruction by
effector T cells, we examined whether there was a change in the
expression of these molecules during rejection compared to normal
kidneys. In normal kidneys, peritubular and glomerular capillaries and
large vessel endothelium expressed ICAM-l and LFA-3, but tubular
cells expressed only low levels of LFA-3. LFA-l-expressing cells,
which were probably macrophages, were observed in the glomerulus. A
few scattered LFA-l-expressing cells in the interstitium were probably
tissue macrophages or dendritic cells, and only occasional interstitial
mononuclear cells expressed LFA-2. During rejection, there was an
infiltrate of mononuclear cells expressing LFA- I and the T cell and NK
cell component of the infiltrate expressed LFA-2. Neither of these
markers was expressed by kidney parenchymal cells except for one
allograft with severe rejection which showed LFA- 1 beta chain expres-
sion by some tubular cells. Tubular cells had increased expression of
ICAM-l during rejection but there was no increase in LFA-3. The
importance of LFA-2 and ICAM-l expression on kidney tubular cells
for adhesion of activated T cells was also examined in an in vitro
system. An assay of binding of lymphocytes to monolayers of cultured
kidney (HK) cells showed that there was greater adhesion of immune-
activated lymphocytes to kidney cells (37.4 4.6% bound) than resting
lymphocytes (14.3 3.5%), and this adhesion was inhibited by anti-
body to LFA-l (59,0 10.1% inhibition) and ICAM-l (34.9 4.4%)but
not to LFA-2 or LFA-3. These results suggest that adhesion of
lymphocytes to HK cells is mediated mainly by a LFA-l-dependent
pathway. As kidney microvasculature constitutively expresses both
adhesion molecules and HLA class I and class II, it is likely that these
cells are the initial targets of effector cells of rejection and are
preferentially destroyed. Increased expression of ICAM-l and HLA
antigens on tubular cells with rejection will also increase their interac-
tion with effector cells and make them more vulnerable to destruction.
Adhesion molecules are essential for non-specific binding
between leukocytes and in the binding of leukocytes to cells of
non-leukocyte origin. Two complementary sets of adhesion
molecules have been identified. Leukocyte function-associated-
1 (LFA-1) is a heterodimer of a 180 kD alpha chain and a 95 kD
beta chain, the latter being common to LFA-i, Mac-i and
p150,95 [reviewed in 1]. LFA-l has been shown to be expressed
Received for publication January 6, 1989
and in revised form May 8, 1989
Accepted for publication July 6, 1989
© 1989 by the International Society of Nephrology
by nearly all leukocytes but not by cells of non-leukocyte
lineage [1]. The ligand for LFA-i in many but not all cases is
intercellular adhesion molecule-i (ICAM-i), a 90 to 110 kD
molecule, expressed in normal tissue by vascular endothelial
cells, dendritic cells, fibroblast-like cells and some epithelial
cells [2, 3]. Expression of ICAM-l is not invariable and can be
induced to increase on cultured fibroblasts and vascular endo-
thelial cells by interleukin 1, tumor necrosis factor and gamma
interferon [3, 4] which are released by immune-activated cells
present in inflammatory episodes such as allograft rejection.
The second set of adhesion molecules is LFA-2 (CD2; 50 to 58
kD), which is expressed by T lymphocytes and natural killer
(NK) cells and its ligand, LFA-3 (55 to 70 kD), which is
expressed by virtually all cell types [5, 61.
The importance of adhesion molecules in lymphocyte func-
tion is demonstrated by a variety of studies. Antibodies to
adhesion molecules block leukocyte and lymphocyte interac-
tions in vitro and inhibit lymphocyte functions such as cytotox-
icity [6, 71 and proliferation in mixed lymphocyte culture [6, 81.
In vivo, antibodies to LFA-1 prevent graft rejection [9, 10).
These observations imply that adhesion molecules may have an
important role in the allograft rejection response and that only
cells which express ligands for the adhesion molecules on
effector lymphocytes as well as the relevant class of MHC
molecules can be recognized by these cells. Because of this we
examined the tissue distribution of these molecules in normal
kidney and examined whether, like MHC expression, LFA-3
and ICAM-1 expression changed during rejection. To examine
the relative contribution of the LFA-1-dependent and the LFA-
2-dependent pathways to non-antigen-specific binding between
lymphocytes and kidney cells, we used an in vitro model in
which antibodies to adhesion molecules were used to block
binding of lymphocytes to kidney cells.
We identified de novo expression of ICAM-i by kidney
tubule cells during rejection, but no change in LFA-3 expres-
sion by these cells. Adhesion of activated lymphocytes to
kidney cells in vitro was blocked by antibody to LFA-i and to
a lesser extent by ICAM-1 but not LFA-2 or LFA-3. Taken
together these results suggest the increased expression of
ICAM-l as well as MHC antigens on kidney tubular cells during
rejection may make them more vulnerable to effector cells.
Methods
Clinical
Twenty-five core renal biopsies were obtained from 24 ca-
daver renal allograft patients. The details of patient manage-
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Table 1. Sources of monoclonal antibodies
Final
concentra-
tion
Antibody jxg/ml Specificity Source Ref
HLA-DR I HLA-DR non-polymor-
phic structure
Becton Dickinsona [25]
HLA-ABC I HLA-ABC non-polymor-
phic structure
AMDb
TS1:22 1 LFA-1 alpha chain Dr. A. Krensky° [2611
TSI:l8 1 LFA-l beta chain Dr. A. Krensky° [26]
OKT11 1.5 LFA-2 (CD2) ATCCd
TS2/9.l.1 1 LFA-3 Dr. A. Krensky° [26]
RR1/l 1 ICAM-1 adhesion
molecule
Dr. T. Springere [2]
RPAMI 3 Monocytes and
macrophages
G. Aversa [27]
OKT3 10 T cells ATCCd
RANA 5 Control (Influenza
neuraminidase)
Dr. R. [28]
a Becton Dickinson, Mountain View, CA, USAb Australian Monoclonal Development, Artarmon, Australia
Dr. A. Krensky, Stanford University Medical Center, CA, USAd American Type Culture Collection, Rockville, MD, USA
Dr. T. Springer, Dana Faber Cancer Institute, Boston, MA, USA
G. Aversa, Stanford University Medical Center, Stanford, CA,
USA
g Dr. R. Raison, Clinical Immunology Research Centre, University of
Sydney, Sydney, Australia
ment have been previously reported [11]. Twelve patients were
on cyclosporine therapy at the time of biopsy and 12 were
treated with azathioprine and prednisone. Biopsies were graded
as severe (N = 9), moderate (N = 9) or minimal (N = 7)
rejection on the basis of previously defined morphological
criteria [12, 13]. Normal kidneys (N = 5) were obtained as
kidneys donated for transplantation but unsuitable for use or as
the unaffected portion of nephrectomies for renal tumor.
Antibodies
Mouse monoclonal antibodies used for these experiments are
shown in Table 1. Some monoclonal antibodies were produced
from clones held in our laboratory. Rabbit antibody to mouse
immunoglobulin was from Dako, Copenhagen, Denmark and
was used at 1:200 dilution. Swine-anti-rabbit immunoglobulin
(Dako) and rabbit peroxidase-antiperoxidase complexes (Dako)
were diluted 1:25 and 1:50, respectively.
Immunoperoxidase stains
Biopsy tissue was divided and part fixed in 5% buffered
formalin and embedded in paraffin for routine light microscop-
ical examination as previously described [12]. The remainder
was embedded in Tissue Tek mounting medium (Miles Labora-
tories, Elkhart, Indiana, USA), fixed in acetone for 18 hours at
—20°C and stained by a four-step indirect immunoperoxidase
technique as previously described [14].
Extent of expression of these molecules on components of
graft or infiltrate was assessed as: +++, expression on >90%
of the component; ++, expression on 40 to 90% of the
component; +, expression on 5 to 40% and; —, expression on
<5% of the component. Total infiltrate was estimated as the
sum of the T cell and natural killer cell infiltrate, identified by
antibody to CD2, and the monocyte/macrophage infiltrate,
identified by RPA Ml. Statistical analysis of the expression of
adhesion molecules was by 4 x 2 contingency table analysis.
Culture and labelling of human kidney cells
HK cells were grown to confluence in monolayer culture in
96-well flat-bottomed tissue culture trays (Costar, Cambridge,
Massachusetts, USA, no. 3596) as previously described [15],
but with 10% (vol:vol) Nu-Serum (Collaborative Research, Two
Oak Park, Bedford, Massachusetts, USA, no. 50004) substi-
tuted for fetal calf serum. The cultured cells, which have been
previously characterized as being of mainly tubular epithelial
morphology and phenotype [15], were grown in serum contain-
ing factors which enhanced the growth of epithelial cells [16]
and which had little bovine serum, to reduce fibroblast contam-
ination. The resulting cultures, which maintained uniform epi-
thelial morphology for at least six subcultures, were used at
passage three or less to minimize contamination with fibro-
blasts. Some kidney cells were treated with lymphokine-con-
taming supernatant from OKT3-activated lymphocytes at a final
concentration of 20% vol:vol in RPMI 1640, 250 d/we1l. HK
cells were analysed for expression of MHC antigens and
adhesion molecules by immunostaining and flow cytometry as
previously described [15] with the modification that 50 d of
first-step monoclonal antibody was added to 50 .d of kidney cell
suspension. Statistical analysis of the expression of adhesion
molecules by HK cells was by Student's t-test.
Activation of T cells
Lymphocytes were prepared from peripheral blood of
healthy volunteers unrelated to the donors of the kidney cells
by Ficoll-Hypaque centrifugation followed by panning on plas-
tic petri dishes to remove adherent cells as previously described
[17]. The non-adherent cells, which were predominantly T cells
(76 12% CD3-positive), were resuspended in RPMI 1640
medium (Irvine Scientific, Santa Ana, California, USA) supple-
mented with 2 m L-glutamine, 50 U/mI penicillin, 50 sg/ml
streptomycin, 20 m HEPES buffer, plus 10% AB serum. A 15
ml aliquot of these cells was activated by incubation for four
days at 37°C in 25 cm2 tissue culture flasks (Corning Co.,
Corning, New York, USA) which had been pretreated by
incubation for one hour with antibody to OKT3 at a concentra-
tion of 10 g/ml, followed by washing to remove unbound
antibody.
Assay of lymphocyte adhesion to HK cells
Activated lymphocytes or normal control peripheral blood
lymphocytes were centrifuged for five minutes at 300 x g and
the cell pellet was labelled by resuspension in 100 Ci of 51Cr
(code CJS-4, Radiochemical Centre, Amersham, UK) for two
hours at 37°C. Cells were washed six times in phosphate-
buffered saline and resuspended at a concentration of 1 X 106
cells/mi in RPMI 1640 medium and 5% human AB serum then
added to kidney cell monolayers, 100 4/well and incubated for
one hour at 37°C. Wells were filled with PBS followed by
aspiration to remove non-adherent cells. This washing step was
repeated a further three times. Adherent cells were lysed by
addition of 200 4/well concentrated HCI and 100 xl aliquots
were counted on a gamma counter. Controls (AC) for the
adhesion step consisted of lymphocytes added to wells without
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Fig. 1. Immunoperoxidase staining shows stained cells as black and unstained tissue as light grey. Sections from normal kidney (A) or from
rejecting renal allograft (B) stained to identify LFA-l alpha chain. Some LFA-l expressing cells are identified in normal kidney, especially in the
glomerulus but also scattered through the interstitium. The infiltrate, but not components of the graft, expresses LFA-l in the rejecting allograft.
kidney cells. For some experiments, lymphocytes and kidney
cells were pretreated for 30 minutes with antibodies to adhesion
molecules or control antibodies (CON) prior to the adhesion
step. Inhibition of adhesion by antibody was calculated accord-
ing to the formula:
EXPT. - AC% Inhibition = (1 — ) x 100CON - AC
Results
Expression of adhesion molecules in normal and transplanted
kidneys
LFA-1 expression, LFA-l alpha and beta chains had a similar
distribution in all sections. In both normal and allograft kidneys
with minimal rejection, they were confined to isolated leuko-
cytes throughout the interstitium and in glomeruli (Fig. 1A).
These glomerular cells had a similar distribution to cells iden-
tified by RPAM1 which stains monocytes and macrophages. No
cells were identified in normal glomeruli with the T cell marker
CD2. Taken together these results suggest that the LFA-
1-expressing cells are tissue macrophages or dendritic cells.
Between 1 to 10 cells are identified per glomerular section. They
are round cells, which do not have the morphology of mesan-
gial, endothelial or epithelial cells and are presumably migrating
macrophages, similar to those described in the rat [181.
During rejection there was a marked increase in expression of
both LFA-l alpha and beta chains which was confined to the
leukocyte infiltrate (Fig. I B). LFA- 1 was not expressed by
tubules, glomeruli or vascular endothelium in normal or reject-
ing kidneys except for one biopsy with severe rejection and a
heavy leukocyte infiltrate which showed staining of approxi-
mately 15% of the tubular cells. In 2 of 12 kidneys with minimal
or no rejection, 4 of 9 with moderate rejection and 3 of 9 with
severe rejection, there was a faint linear staining pattern in the
interstitium of the kidney evident over less than 15% of the
specimen. This staining is similar to that seen with stains for
peritubular capillaries [19], although it may have been due to
long processes of infiltrating cells in the peritubular areas. This
staining of cells with morphology of peritubular capillaries was
more often observed with the antibody to LFA-1 beta chain (9
biopsies) than to the alpha chain (2 biopsies).
ICAM-1 expression. ICAM-1 was expressed strongly by large
vessel endothelium, peritubular capillaries and by glomeruli in
normal kidneys, but not by renal tubular cells (Fig. 2A). With
rejection, expression by tubular cells was markedly increased
(P C 0.0005; Figs. 2B, 3). Expression by peritubular capillaries
could not be easily evaluated as there was an interstitial
infiltrate of ICAM-1-expressing cells. The inability to observe
peritubular capillaries may be either because they are destroyed
by rejection or because the ICAM- 1-expressing infiltrate ob-
scures their observation (Fig. 2B). Expression of ICAM-l by
glomeruli and by large vessel endothelium was unchanged with
rejection. The infiltrate in the rejecting biopsies expressed
ICAM-l with moderate to strong intensity.
LFA-2 expression. LFA-2 (CD2) was expressed on a very
small number of lymphocytes or natural killer cells in normal
kidneys (Fig. 4A). During rejection between 20% to 60% of the
infiltrate expressed LFA-2 (Fig. 4B). LFA-2-expressing mono-
nuclear cells were seen in rejecting grafts but not in normal
kidneys. No graft cells expressed LFA-2 either in normal
kidneys or in rejecting renal allografts.
LFA-3 expression. LFA-3 was expressed by all cells in
normal kidneys. The expression on tubular cells was weaker
than the moderate to strong expression by glomeruli, large
vessel endothelium and peritubular capillaries (Fig. 5A).
Expression of LFA-3 on peritubular capillaries was less easily
defined than ICAM-l. With rejection, the infiltrate showed
weak to moderate expression of LFA-3 and there was no
definite increase in expression by kidney components (Fig. SB).
The linear staining pattern of LFA-3 expression which was
characteristic of peritubular capillaries, was less often observed
in rejecting grafts (Fig. SB). This may have been due either to
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Fig. 2. Sections from normal kidney (A) or from rejecting renal allograft (B) stained to identify ICAM-1. ICAM-l is expressed by the vasculature
of normal kidneys, including pentubular and glomerular capillaries and large vessel endothelium but not by tubular cells. During rejection, there
is a marked increase in expression of ICAM- 1 on tubular cells of the graft while expression of ICAM- 1 by peritubular capillaries has decreased or
been obscured by the ICAM-l-expressing infiltrate.
Fig. 3. Expression of ICAM-] by tubular cells. Amount of tubular
ICAM- 1 was graded from — to + + -4- for each biopsy and the percentage
of biopsies with each grade is shown. Sections were grouped according
to severity of rejection as: minimal (D); moderate (0); and severe (•).
Groups were compared by Brandt-Snedecor contingency table analysis
and there was a significant increase in expression of tubular ICAM- I
with rejection. There was a significant (P < 0.0005) increase in
expression in the moderate and severe rejection groups compared to the
minimal rejection.
destruction of these capillaries with rejection or to obstruction
by the LFA-3-expressing infiltrate, although the latter is un-
likely as the infiltrate did not strongly express LFA-3. Strong
LFA-3 expression by large vessel endothelium or glomeruli was
unchanged with rejection.
Expression of adhesion molecules and MHC antigens by
kidney cells in culture
To examine whether ICAM-l expression was induced by the
same mechanisms of cytokine-mediated induction as MHC
antigens in HK cell cultures, HK cells were untreated or treated
for four days with lymphokines from activated T cells. They
were analyzed for changes in expression of adhesion molecules
by immunostaining and flow cytometry (Fig. 6). HK cells
expressed LFA-3 with low intensity in accord with immuno-
staining results of normal kidneys (Fig. 5A), and there was no
change in the weak expression of LFA-3 with culture with
lymphokines. Untreated HK cells expressed ICAM-l and
HLA-ABC with moderate intensity which is in contrast to the
low or undetectable expression of these antigens on normal
kidney tubular cells (Fig. 2A) [19]. Treatment of the HK cells
with lymphokines increased their intensity of expression of
HLA-ABC (P = 0.05, N = 5), but did not change the proportion
of cells stained. De novo expression of HLA DR was seen in
accord with the increased expression of these antigens ob-
served in rejecting kidneys [20]. Expression of ICAM-l by
lymphokine-treated HK cells was greater than untreated HK
cells in all experiments, however, the increase was not signifi-
cant (P = 0.13, N = 5) due to the variability of expression
between experiments. LFA-l and LFA-2 were not expressed
by cultured HK cells.
Adhesion of lymphocytes to HK cells
To examine whether the change in expression of ICAM-l is
necessary for effective activated T cell binding, adhesion of
lymphocytes to monolayers of cultured HK cells was examined
(Table 2). Polyclonal activation of T cells was obtained by
treating normal peripheral blood lymphocytes in culture with
OKT3. Human kidney cell monolayer cultures were tested,
either with or without lymphokine treatment. A greater propor-
tion (37.4 4.5%, mean SD of 12 experiments) of activated
lymphocytes bound to the HK cell monolayer compared to
resting lymphocytes (11.5 3.1%). Lymphokine-pretreatment
of kidney cell cultures did not increase binding of resting
lymphocytes but caused a slight increase in binding of activated
Fig. 4. Sections from normal kidney (A) or from rejecting renal allograft (B) stained to identify LFA-2 (CD2). Few LFA-2 expressing cells are
identified in normal kidney while the some of the infiltrate, but not components of the graft, expresses LFA-2 in the rejecting allograft. Note the
LFA-2-expressing cells in the glomerulus during rejection. This marker identifies T cells and NK cells.
Fig. 5. Sections from normal kidney (A) or from rejecting renal allograft (B) stained to identify LFA-3. LFA-3 is expressed with moderate intensity
by the vasculature of normal kidneys, including peritubular and glomerular capillaries and large vessel endothelium and weakly by tubular cells.
During rejection, there is no increase in expression of LFA-3 by the graft and expression of LFA-3 by the peritubular capillaries has decreased
or been obscured by the infiltrate. There is weak to moderate expression of LFA-3 on infiltrating leukocytes.
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lymphocytes (43.2 4.5% binding, P 0.0005, N = 18). plus HLA-DR did not inhibit binding of lymphocytes to HK
Adhesion of lymphocytes to kidney cell monolayers was re- cells.
duced when adhesion was performed at 4°C (Table 2).
To examine which molecules were critical in facilitating this
adhesion of activated lymphocytes to HK cells, inhibition with
monoclonal antibodies to adhesion molecules was tested (Fig.
7). Antibody to LFA-1 inhibited adhesion to untreated HK cells
by 59.0 10.1% and to lymphokine-pretreated BK cells by 52.0
10.6%. Antibody to ICAM-1 inhibited binding to untreated
HK cells by 34.9 4.4% and to lymphokine-treated HK cells
by 10.0 8.5%. Antibody to LFA-2, LFA-3 and to HLA-ABC
Discussion
T cells are central to the allograft rejection response and their
interactions with graft stimulator or target cells are dependent
upon specific interaction of the T cell antigen receptor with the
allo-MHC of the stimulator or target cell. In addition, the
stabilization of the interaction by binding of the lymphocyte
CD4 to the graft cell MHC class II antigen and of lymphocyte
CD8 to graft cell MHC class I is thought to be important [21].
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Fig. 6. Expression of adhesion molecules and HLA antigens by cul-
tured human HK cells with (U) and without (fl) pretreatment with
lymphokines from activated T cells. HK cells were stained by indirect
immunofluorescence and analyzed by flow cytometry. Top panel shows
percentage of cells positive and bottom panel shows intensity of
staining on a scale of increasing intensity ranging from 0 to 250. There
was significant increase in intensity of expression of HLA-ABC (P =
0.05) and HLA-DR (P = 0.03) as well as the proportion of cells
expressing HLA-DR (P = 0.03). Other markers were unchanged with
lymphokine treatment, although ICAM-l showed a tendency to in-
crease with pretreatment (P = 0.13) and was expressed to a greater
extent on pretreated cells compared to control cells in all experiments.
Table 2. Adhesion of lymphocytes to cultured kidney cells
Adhesion
temperature
Resting lymphocytes Activated lymphocytes
37°C 4°C 37°C 4°C
Untreated HK 11.5 3.l 6.6 3.4 37.4 4.6 14.3 3.5
cells
Lymphokine- 12.6 3.9 5.9 1.9 43.2 4.5 16.5 4.0
pretreated
HK cells
a Figures show percentage of lymphocytes bound to kidney cell
monolayer
LFA1 LFA2 LFA3 ICAM1 HLA ABC
+ HLA DR
Antibody added
Fig. 7. Inhibition with monoclonal antibodies to adhesion molecules of
adhesion of activated lymphocytes to monolayers of HK cells. Vertical
bars show percentage inhibition of binding to untreated kidney cell
monolayers (El) or to HK cells which had been pretreated with
lymphokines (U). Activated lymphocytes treated with control antibody
showed binding of 40.4 1.3% to untreated HK cells and of 45.8 6%
cells to lymphokine-pretreated HK cells (N = 5). The results for
percentage inhibition shown here are calculated using these control
values according to the formula in the methods section. There was
significant inhibition with anti-LFA- 1 (P = 0.002) and to a lesser extent
with anti-ICAM-l (P = 0.001). Anti-LFA-2, anti-LFA-3 and anti-HLA
did not inhibit adhesion.
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blood monocytes and tissue macrophages, but were not stained
with antibody to LFA-2 which is present on T cells and NK
cells. In previous studies, no B cells or macrophages have been
identified in the glomeruli of normal kidneys [13, 22], probably
due to the ability of the reagents used to identify only a fraction
of tissue macrophages. LFA-1 is broadly distributed on human
leucocytes, however, and may identify glomerular macro-
phages. Thus it is possible that the 1 to 5 LFA-l-expressing
cells identified in each glomerular section correspond to the 5 to
10 migrating macrophages seen per glomerulus in normal rat
kidneys [181.
During rejection there was no induction of expression of
LFA-l or LFA-2 on graft components, except for one allograft
biopsy with severe rejection and a heavy leucocyte infiltrate
which expressed LFA-l beta chain, but not alpha chain on a
minority of tubular cells. There was some slight staining with
LFA-l which showed the linear morphology suggestive of
peritubular capillaries, although this may also have been the
long processes of infiltrating leukocytes. It thus appears that
LFA- 1 and LFA-2 are confined to the infiltrate and there is little
or no expression of these molecules by kidney structures even
during rejection.
Normal kidney glomeruli, large vessel endothelium, and
pentubular capillaries expressed LFA-3 moderately strongly
and ICAM-l strongly. In contrast, tubular cells of normal
kidneys did not express ICAM-l but did express LFA-3 with
slight to moderate intensity. The main change in expression of
LFA antigens observed during rejection was that tubules were
induced to strongly express ICAM- 1. Expression of ICAM- 1
and LFA-3 by large vessel endothelium and by glomerular
capillaries was unchanged with rejection, while their expression
The specific binding of lymphocytes to graft cells is facilitated
and stabilized by non-specific binding mediated by adhesion
molecules LFA-l and LFA-2 on lymphocytes which bind
respectively to ICAM-l and LFA-3 on the graft.
As expected from published reports of the distribution of
these adhesion molecules [1, 6], LFA-l and LFA-2 were not
expressed by normal kidney parenchymal cells. Scattered cells
in the interstitium and many mononuclear cells in glomeruli
expressed LFA-l alpha and beta chains and probably represent
macrophages. Rare LFA-2 (CD2)-expressing cells in the inter-
stitium were probably T cells or NK cells. Of particular interest
was the staining of large mononuclear cells in the glomeruli of
normal kidneys with antibodies to the LFA- 1 alpha and beta
chains. Mononuclear cells in the glomerulus also stained
weakly with the antibody RPA-Ml, which identifies peripheral
1084 Bishop and Hall: Expression of adhesion molecules
by peritubular capillaries was either decreased or obscured by
infiltrate during rejection.
Expression of adhesion molecules by cultured human kidney
cortical (HK) cells, was examined. Expression of adhesion
molecules by these cells was consistent with their expression by
tubular cells of normal kidneys as identified by immunostaining.
Cultured kidney cells did not express LFA- 1 or LFA-2 while
they did express LFA-3, and this expression was unchanged
with pretreatment of the IlK cells with supernatants from
activated T cells, in support of the in vivo findings. In contrast
to the in vivo findings, HK cells expressed ICAM-l and
HLA-ABC, while tubular cells in sections from normal kidney
did not, suggesting that culture of kidney tubular cells sponta-
neously increased their expression of ICAM-l and ElLA-ABC.
Treatment of cultured cells with lymphokine-containing super-
natants from activated T cells increased their intensity of
expression of HLA-ABC, and there was a trend for increased
expression of ICAM- I, although the increase was not statisti-
cally significant (P = 0.13). In addition, HLA-DR expression
was induced de novo as has been previously described [151.
This increase in expression of HLA-ABC, HLA-DR and pos-
sibly of ICAM-1, on cultured kidney cells is in accord with the
results of immunostaining of biopsies from rejecting grafts in
which renal tubular cells increased their expression of ICAM- 1,
and of HLA-ABC and HLA-DR as has been previously de-
scribed [13, 20]. Similarly, fibroblasts can be induced to express
increased amounts of ICAM-l with gamma interferon or inter-
leukin-l [3].
As T cells express both LFA- 1 and LFA-2 and graft cells
express LFA-3 and sometimes ICAM- 1, it is possible that T
cells can bind to graft components via both the LFA- 1 to
ICAM-l pathway and the LFA-2 to LFA-3 pathway. Tha
contribution of these two adhesion pathways to binding of
lymphocytes to graft cells was examined using an in vitro
model. Lymphocytes which had been polyclonally activated by
incubation with immobilized antibody to CD3 were more ad-
herent to kidney tubular cells than were resting lymphocytes.
Antibody to LFA- 1 partially blocked adhesion of activated
lymphocytes to kidney cells while antibody to LFA-2 and
LFA-3 did not inhibit binding. Antibody to ICAM-l inhibited
binding however this was less than inhibition by LFA- I, indi-
cating either that ICAM-1 is not the only ligand on cultured
kidney cells for lymphocyte LFA- 1, or that the antibody to
ICAM-1 is a less efficient blocker of binding than the antibody
to LFA- 1. Consistent with the former hypothesis is the recent
report of ICAM-2, which is a second ligand for LFA-l [231.
Taken together, these results suggest that adhesion of lympho-
cytes to tubular cells in vitro is mediated mainly by LFA-l and
not by LFA-2 or LFA-3, but that target cell ligands other than
ICAM-l may also be involved. As the LFA-l-dependent path-
way is inhibited at 4°C and the LFA-2-dependent pathway is not
[51 the fact that adhesion of lymphocytes to kidney cells is
inhibited by incubation at 4°C is further evidence that the
LFA-1-dependent pathway is dominant in this model. Lympho-
kine treatment of ElK cells resulted in a slight but significant
increase in their ability to bind activated lymphocytes. As
ICAM-1 was the only adhesion molecule which tended to
increase on these treated HK cells, it is possible that the
increased binding observed was due to increased expression of
either ICAM- 1 or to an unidentified adhesion molecule which
was increased in expression as a result of lymphokine treatment
of HK cells. The increase in HLA-ABC and DR did not appear
to be a factor as monoclonal antibodies to these did not block
adhesion. This is not surprising as in this assay the T cells were
polyclonally activated and only a minority might be expected to
recognize the allo-HLA on the cultured HK target. Thus this
assay only examined non-specific binding and not specific
binding mediated by the T cell receptor.
If LFA-1-mediated adhesion is also dominant in vivo, graft
cells expressing the ligand for leukocyte LFA-1, such as ICAM-
1, would be more likely to interact with infiltrating mononuclear
cells. Examination of the pattern of expression of adhesion
molecules in normal and rejecting renal allografts has identified
the vascular endothelium of the graft as the cells with the
highest constitutive expression of LFA-3 and ICAM-l. This
expression, together with their high expression of HLA-ABC
and DR may result in preferential binding of activated effector
cells and may be a contributing factor in the preferential
destruction of capillary endothelial cells observed in rejecting
human [191 and rat [24] renal allografts. Renal tubular cells
which normally express low levels of adhesion molecules and
HLA antigens show increased expression of both ICAM-l and
HLA during rejection by exposure to T cell-derived lymphok-
ines. This may render these cells more susceptible to immune
destruction in that ligands critical for effector cell adhesion as
well as HLA antigens, which are the ligands of the T cell
receptor, are increased in their expression by these cells.
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